We read with great interest the letter to the editor submitted by Dr David C. Metz.1 We are grateful for his engagement with this important clinical practice update on exocrine pancreatic insufficiency (EPI)2 and appreciate the opportunity to address his comments.
We will be happy to hear your thoughts